Endogenous opiates and behavior: 2022

RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Pharmacogenetics approach for the improvement of COVID-19 treatment

I Fricke-Galindo, R Falfán-Valencia - Viruses, 2021 - mdpi.com
The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy
of several drugs has been evaluated and variability in drug response has been observed …

[HTML][HTML] Bioactive hexapeptide reduced the resistance of ovarian cancer cells to DDP by affecting HSF1/HSP70 signaling pathway

R Guo, Q Xu, L Liu, H Liu, Y Liu, W Wei, Y Qin - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Ovarian cancer is the leading cause of death in gynecologic malignancies. Ovarian cancer
as a metastatic malignant tumor is highly recurrent and prone to drug resistance. Bioactive …

Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor …

A Muderrisoglu, E Babaoglu, ET Korkmaz… - Frontiers in …, 2022 - frontiersin.org
Objective: To investigate the effects of genetic polymorphisms of human nicotinic
acetylcholine receptor subunits α3, α4 and α5, which are encoded by CHRNA3, CHRNA4 …

[HTML][HTML] Tratamiento del tabaquismo guiado por marcadores genéticos

G Hincapié-López, C Isaza-Mejía… - Revista Médica de …, 2023 - scielo.org.co
Introducción: Entre las adicciones por drogas, el tabaquismo ocupa el primer lugar como
causa de morbimortalidad y es factor de riesgo para seis de las ocho principales causas de …

Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice

KI Bentsionova, ZI Rossokha… - Medicni …, 2023 - search.proquest.com
Thromboembolic diseases are of great clinical concern because of their high prevalence
and consequences, which are often fatal. Despite significant progress in the prevention and …

Фармакогенетичне обґрунтування персоналізованого призначення пероральних антикоагулянтних препаратів у клінічній практиці

КІ Бенціонова, ЗІ Россоха… - Медичні перспективи …, 2023 - repo.dma.dp.ua
Тромбоемболічні захворювання викликають велике клінічне занепокоєння через їх
високу поширеність і наслідки, які часто є летальними. Незважаючи на суттєвий …

Study progress on pharmacogenomics of sodium-glucose linked transporter 2 inhibitors

Z Yongru, S Jinfang - China Pharmacy, 2024 - journal.china-pharmacy.com
odium-glucose linked transporter 2 inhibitors (SGLT2i) are novel oral hypoglycaemic agents
and are widely used for hypoglycemic therapy in patients with type 2 diabetes mellitus, but …

[PDF][PDF] Understanding genetics and genetic polymorphism in tobacco cessation: A public health perspective

D Gurung, VK Bhardwaj, S Fotedar, AS Thakur - 2022 - oraljournal.com
Genetics has played a significant role in the interaction between the tobacco use and its
environment which is evident through molecular epidemiological studies. This has come a …

C3435T Polymorphism of the ABCB1 gene in the Yakut Population

NI Pavlova, AT Diakonova, VA Alekseev… - International Journal of …, 2021 - elibrary.ru
Background: The ABCB1 gene is responsible for resistance to various cytotoxic drugs. The
product of the ABCB1 gene, P-glycoprotein (P-gp), acts as a transmembrane pump and …